DK1173176T3 - Anvendelse af polycycliske 2-aminothiazolsystemer til fremstilling af medikamenter til forebyggelse eller behandling af obesitas - Google Patents

Anvendelse af polycycliske 2-aminothiazolsystemer til fremstilling af medikamenter til forebyggelse eller behandling af obesitas

Info

Publication number
DK1173176T3
DK1173176T3 DK00905028T DK00905028T DK1173176T3 DK 1173176 T3 DK1173176 T3 DK 1173176T3 DK 00905028 T DK00905028 T DK 00905028T DK 00905028 T DK00905028 T DK 00905028T DK 1173176 T3 DK1173176 T3 DK 1173176T3
Authority
DK
Denmark
Prior art keywords
treatment
aminothiazole
obesity
polycyclic
systems
Prior art date
Application number
DK00905028T
Other languages
Danish (da)
English (en)
Inventor
Gerhard Jaehne
Karl Geisen
Hans-Jochen Lang
Martin Bickel
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK1173176T3 publication Critical patent/DK1173176T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Child & Adolescent Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DK00905028T 1999-02-26 2000-02-05 Anvendelse af polycycliske 2-aminothiazolsystemer til fremstilling af medikamenter til forebyggelse eller behandling af obesitas DK1173176T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19908537A DE19908537A1 (de) 1999-02-26 1999-02-26 Verwendung von polycyclischen 2-Amino-Thiazol Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas

Publications (1)

Publication Number Publication Date
DK1173176T3 true DK1173176T3 (da) 2004-09-27

Family

ID=7899081

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00905028T DK1173176T3 (da) 1999-02-26 2000-02-05 Anvendelse af polycycliske 2-aminothiazolsystemer til fremstilling af medikamenter til forebyggelse eller behandling af obesitas

Country Status (16)

Country Link
US (1) US6476059B1 (ja)
EP (1) EP1173176B1 (ja)
JP (1) JP4728483B2 (ja)
KR (1) KR20020002394A (ja)
CN (1) CN1161120C (ja)
AT (1) ATE267597T1 (ja)
AU (1) AU766295B2 (ja)
BR (1) BR0008557A (ja)
CA (1) CA2362554A1 (ja)
DE (2) DE19908537A1 (ja)
DK (1) DK1173176T3 (ja)
ES (1) ES2218122T3 (ja)
HK (1) HK1045809B (ja)
PT (1) PT1173176E (ja)
WO (1) WO2000051602A1 (ja)
ZA (1) ZA200106199B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19908538A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Thiazol Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
JP2002543067A (ja) * 1999-04-22 2002-12-17 シナプティック・ファーマスーティカル・コーポレーション 選択的なnpy(y5)のアンタゴニスト
AU2001246494A1 (en) * 2000-03-03 2001-09-12 Novartis Ag Condensed thiazolamines and their use as neuropeptide y5 antagonists
EP1305023A4 (en) * 2000-08-01 2005-02-23 Univ Virginia USE OF SELECTIVE AGONISTS, ANTAGONISTS AND ALLOSTERIC AMPLIFIERS OF THE ADENOSINE A1 RECEPTOR TO INFLUENCE THE ANGIOGENESIS
WO2003061655A1 (en) * 2002-01-16 2003-07-31 University Of Virginia Patent Foundation 2-aminothiazole allosteric enhancers of a1 adenosine receptors
WO2004110338A2 (en) * 2003-06-12 2004-12-23 Biomas Ltd. Methods of treating obesity and related disorders using tellurium and selenium compounds
JP2008508336A (ja) 2004-08-05 2008-03-21 エフ.ホフマン−ラ ロシュ アーゲー 置換されたn−アシル−2−アミノチアゾール
WO2006080406A1 (ja) * 2005-01-28 2006-08-03 Taisho Pharmaceutical Co., Ltd. 三環性化合物
PL2276767T3 (pl) 2008-03-31 2014-09-30 Genentech Inc Związki benzopiranowe i benzoksepinowe będące inhibitorami pi3k oraz metody ich stosowania
SG10201407781SA (en) 2009-09-28 2015-01-29 Hoffmann La Roche Benzoxepin PI3K Inhibitor Compounds And Methods Of Use
RS53164B (en) 2009-09-28 2014-06-30 F. Hoffmann-La Roche Ag BENZOXAZEPINE PI3K INHIBITOR COMPOUNDS AND THEIR USE IN CANCER TREATMENT
CA2825966A1 (en) 2011-03-21 2012-09-27 F. Hoffmann-La Roche Ag Benzoxazepin compounds selective for pi3k p110 delta and methods of use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507868A (en) * 1968-10-21 1970-04-21 Sandoz Ag Imidazo(2,1-b)thiazoles and thiazolo(3,2-a)pyrimidines
DE2640358A1 (de) * 1976-09-08 1978-03-16 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
JPS5334471A (en) * 1976-09-10 1978-03-31 Toshiba Corp Manufacture for semiconductor device
CA1292226C (en) * 1986-01-16 1991-11-19 Terumi Hachiya Indenothiazole derivative and process for preparing the same
IE68593B1 (en) * 1989-12-06 1996-06-26 Sanofi Sa Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them
DE19831878C2 (de) * 1998-07-17 2001-05-17 Aventis Pharma Gmbh Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908538A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Thiazol Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen

Also Published As

Publication number Publication date
KR20020002394A (ko) 2002-01-09
DE50006603D1 (de) 2004-07-01
ATE267597T1 (de) 2004-06-15
WO2000051602A1 (de) 2000-09-08
BR0008557A (pt) 2001-12-18
CN1161120C (zh) 2004-08-11
HK1045809A1 (en) 2002-12-13
JP2002538117A (ja) 2002-11-12
CN1349404A (zh) 2002-05-15
JP4728483B2 (ja) 2011-07-20
PT1173176E (pt) 2004-09-30
AU766295B2 (en) 2003-10-16
EP1173176A1 (de) 2002-01-23
EP1173176B1 (de) 2004-05-26
ES2218122T3 (es) 2004-11-16
ZA200106199B (en) 2002-03-06
AU2670300A (en) 2000-09-21
CA2362554A1 (en) 2000-09-08
US6476059B1 (en) 2002-11-05
DE19908537A1 (de) 2000-08-31
HK1045809B (zh) 2005-04-22

Similar Documents

Publication Publication Date Title
BR0208678A (pt) Composto, composição farmacêutica, uso de um composto
MY137039A (en) Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
BR0109703A (pt) Derivados de piperazina
MY139302A (en) Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
BR0208338A (pt) Derivados de piridina
AR020662A1 (es) Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento.
DE60324014D1 (de) Heterocyclische verbindungen alsccr5-antagonisten
DK1173176T3 (da) Anvendelse af polycycliske 2-aminothiazolsystemer til fremstilling af medikamenter til forebyggelse eller behandling af obesitas
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
GEP20053617B (en) Bridged Piperazine Derivatives
PT1156805E (pt) Utilizacao de sistenas piliciclicos de tiazole para a fabricacao de medicamentospara a profilaxia ou o tratamento de obesidade
PT1157015E (pt) Utilizacao de sistemas 2-amino-triazole policiclicos para a preparacao de medicamentos para tratamento de perturbacoes lipometabolicas, da obesidade e da diabetes tipo ii
DZ3459A1 (fr) Derives de 2h-1-benzopyran, procedes de preparation de ces derniers et compositions pharmaceutiques dans lesquels ils entrent.
MXPA04001847A (es) Uso de sistemas de indan-1-ol polisbstituidos para producir drogas utilizadas en la profilaxis o tratamiento de la obesidad.
ATE296295T1 (de) Polycyclische thiazol-systeme und ihre verwendung als anorektika
CY1106129T1 (el) Κιταλοπραμη για την αγωγη της υψηλης πιεσεως του αιματος
DK1425007T3 (da) Anvendelse af C2-substituerede indan-1-ol-systemer til fremstilling af medikamenter til profylaxe eller behandling af obesitas
ATE306483T1 (de) Alkoxy-substituierte benzimidazolverbindungen , diese enthaltende arzneimittel und ihre verwendung
BR0008559A (pt) Aminas tiazol-2-ilideno policìclicas, processos paraa sua preparação e seu emprego comomedicamento